Study: relationship between obesity and clinical risks from prostate cancer

A recent study at Tacoma/Valley Radiation Oncology Centers, suggests that among patients diagnosed with prostate cancer, BMI did not correlate with Gleason score or percent of positive biopsy cores. Researchers reveal there were no statistically significant differences in cancer location among the different BMI groups. They concluded that in this study, obesity did not predispose toward higher Gleason score, larger cancer volume, or geographic cancer distribution on repeat biopsy with transperineal template-guided mapping biopsy.